Mastering Next Generation Stimulant Formulations and Delivery Systems for Individualized Patient Care Across the Lifespan in ADHD

ADHD can present differently across the lifespan, and comorbidities and differences in symptom expression can complicate timely diagnosis. This session reviews evidence-based diagnostic approaches and the design, pharmacology, and clinical evidence behind newer stimulant formulations and delivery systems. Faculty will examine how age, comorbidities, adherence, and dosing needs inform treatment selection. Through shared decision-making, participants will explore how to align treatment with each patient’s preferences and functional goals.

Supported by an educational grant from Collegium Pharmaceutical, Inc.